LABU vs XBIX: which held to its multiple?

Over three months against its own daily promise, LABU finished 1.9 points short and XBIX 2.5 points short. Direxion Daily S&P Biotech Bull 3X ETF and Corgi U.S. Biotech 2x Daily ETF.

−5.8%
LABU returned, 3 months
−3.1%
XBIX returned, 3 months
−8.0 pts
LABU from its stated multiple
−4.6 pts
XBIX from its stated multiple
LABU · 3 months to Sep 30, 20268 pts short of its stated multiple
8 pts short of its stated multipleLABU returned −5.8% while 3 times XBI's move would have been +2.2%XBI +0.7% ×3 implies+2.2%LABU returned−5.8%8 pts short of its stated multipleLABU returned −5.8% while 3 times XBI's move would have been +2.2%XBI +0.7% ×3 implies+2.2%LABU returned−5.8%

LABU returned −5.8% while 3 times XBI's move would have been +2.2%

XBIX · 3 months to Sep 30, 20264.6 pts short of its stated multiple
4.6 pts short of its stated multipleXBIX returned −3.1% while 2 times XBI's move would have been +1.4%XBI +0.7% ×2 implies+1.4%XBIX returned−3.1%4.6 pts short of its stated multipleXBIX returned −3.1% while 2 times XBI's move would have been +1.4%XBI +0.7% ×2 implies+1.4%XBIX returned−3.1%

XBIX returned −3.1% while 2 times XBI's move would have been +1.4%

ETFIQ Decay Resistance Score · LABU scores higherDid it keep up with its own daily multiple, compounded day by day?
0.1, the lowest in this set99.9, the highest

A percentile among the 470 leveraged ETFs, long, over three months. It is a position in a set, not a rating, and neither end of it is a recommendation. All leveraged ETFs ranked by it → How it is computed →

Performance, window by window

Total returnMultiple would giveDifference
WindowLABUXBIXLABUXBIXLABUXBIX
1 month−10.3%−6.8%−8.9%−5.9%−1.4 pts−0.9 pts
3 months−5.8%−3.1%+2.2%+1.4%−8.0 pts−4.6 pts
6 months+56.7%not published+68.3%not published−11.7 ptsnot published
1 year+185.4%not published+174.1%not published+11.4 ptsnot published
3 years+254.5%not publishednot meaningfulnot publishednot meaningfulnot published
Since launch
LABU May 2015 · XBIX Jun 2026
−91.3%+39.1%not meaningful+43.1%not meaningful−4.1 pts

LABU and XBIX over each window. Every figure is an ETFIQ calculation with distributions reinvested. Source: ETFIQ. Open the live comparison on ETFIQ →

On the same fields

LABU
Direxion Daily S&P Biotech Bull 3X ETF · Aims to return three times the daily move of biotech (XBI)
XBIX
Corgi U.S. Biotech 2x Daily ETF · Aims to return twice the daily move of biotech (XBI)
Issuer Direxion Corgi
Sets out to return +3x +2x
Underlying asset XBI XBI
Segment sector sector
Fund returned, 3 months or since launch −5.8% −3.1%
Underlying returned, over that window +0.7% +0.7%
What the stated multiple implies, over that window +2.2% +1.4%
Difference from stated, over that window −8.0 pts −4.6 pts
Fund returned, 1 year or since launch +185.4% +39.1%
Difference from stated, over that window +11.4 pts −4.1 pts
Underlying volatility 29% 29%
Expense ratio 0.96% 0.45%
Launched May 28, 2015 Jun 3, 2026
Net assets $603m $535,942

LABU and XBIX on the same fields, as of Sep 30, 2026. Source: ETFIQ.

LABU in plain words

Three months to Sep 30, 2026: LABU returned −5.8% where its own daily promise gave −4.0%, 1.9 points short. Read the multiple against the whole window instead and 3 times XBI's 0.7% implies +2.2%, which makes LABU look 8.0 points short. 6.1 of that is daily compounding, which happens to any 3 times fund over the same path, and the rest is the fund. LABU aims to return +3 times XBI's move each day, then resets. Over one day it does that. Over longer, the daily results compound, so the total is not +3 times the period's move: in a market that falls and comes back it is reliably less, and in a steady run it can be more. XBI moved at 29% annualized over that window. That is what decides how far the two figures separate: the same fund on a calm underlying and a violent one is a different product.

XBIX in plain words

Three months to Sep 30, 2026: XBIX returned −3.1% where its own daily promise gave −0.6%, 2.5 points short. Read the multiple against the whole window instead and 2 times XBI's 0.7% implies +1.4%, which makes XBIX look 4.6 points short. 2.1 of that is daily compounding, which happens to any 2 times fund over the same path, and the rest is the fund. XBIX aims to return +2 times XBI's move each day, then resets. Over longer, the daily results compound, so the total is not +2 times the period's move: in a market that falls and comes back it is reliably less, and in a steady run it can be more.

Questions people ask

Which came closer to its stated multiple, LABU or XBIX?
Over the window to Sep 30, 2026, LABU finished 8.0 points from what its multiple implies and XBIX finished 4.6 points from its own, so XBIX came closer. Neither figure predicts the next window: it depends on how much the underlying moves about.
Are LABU and XBIX levered on the same thing?
Yes. Both are levered on biotech, LABU at +3 times and XBIX at +2 times the daily move.
Which one decays faster, LABU or XBIX?
Decay follows how much the underlying moves about. Over this window LABU’s moved at 29% annualized and XBIX’s at 29%, so LABU has the rougher ride and, at the same multiple, loses more to compounding.
Can I hold LABU or XBIX for a year?
Both reset every day, so the multiple in the name applies to a single day and the daily results compound. Over a year the total is not the multiple times the year’s move, and in a market that falls and comes back it is reliably less. ETFIQ makes no recommendation either way.
Which is cheaper, LABU or XBIX?
LABU charges 0.96% a year and XBIX charges 0.45%, so XBIX is cheaper. Fees come from each fund's prospectus.
Cite this page

ETFIQ, LABU against XBIX, data as of Sep 30, 2026. https://etfiq.com/compare/leverage/labu-vs-xbix

Open data

Free to use with attribution. Every figure is calculated from a named public source; the method is at etfiq.com/methodology.